The role of thrombospondin-1 in dermatological conditions
Li-Shanjie Chen1,2, Bo-Wen Zheng1,2, Chuan-Ying Zhao1,2
1Department of Dermatology, The First Hospital of China Medical University, Shenyang, China.
Thrombospondin-1 (THBS1) is a multifunctional extracellular matrix protein that interacts with various cell surface receptors, including cluster of differentiation 36 (CD36), CD47, and integrins, as well as secreted proteins such as angiogenic factors and transforming growth factor (TGF)-β. THBS1 drives the development of various skin diseases at the molecular level by modulating core pathological processes, such as angiogenesis, fibrosis, inflammation, and tumor progression, thereby serving as a pivotal nexus between fundamental research and clinical dermatology. This review systematically explores the molecular mechanisms of THBS1 signaling in the skin, highlighting its implications in wound healing, tissue regeneration, inflammatory responses, fibrosis, and skin tumor development. By examining these aspects, we aim to elucidate the multifaceted roles of THBS1 in clinically refractory skin diseases and its translational potential as a therapeutic target.
Thrombospondin-1 (THBS1) is a multifunctional extracellular matrix protein that interacts with various cell surface receptors, including cluster of differentiation 36 (CD36), CD47, and integrins, as well as secreted proteins such as angiogenic factors and transforming growth factor (TGF)-β. THBS1 drives the development of various skin diseases at the molecular level by modulating core pathological processes, such as angiogenesis, fibrosis, inflammation, and tumor progression, thereby serving as a pivotal nexus between fundamental research and clinical dermatology. This review systematically explores the molecular mechanisms of THBS1 signaling in the skin, highlighting its implications in wound healing, tissue regeneration, inflammatory responses, fibrosis, and skin tumor development. By examining these aspects, we aim to elucidate the multifaceted roles of THBS1 in clinically refractory skin diseases and its translational potential as a therapeutic target.
More Related Videos
07:09Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
09:06Assessment of Acute Wound Healing using the Dorsal Subcutaneous Polyvinyl Alcohol Sponge Implantation and Excisional Tail Skin Wound Models.
Published on: March 25, 2020
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Desmosomes
Venous Thrombosis I: Introduction
Intracellular Signaling Affects Focal Adhesions
Some...
